Cristina Elena Brickman, MD
Infectious Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 19 years
- Columbia University College of Physicians and Surgeons, 2007
Offices
2 locations · University of California San Francisco · 1,780 clinicians in this group
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brickman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$23,524
Medicare paid this office $23,524 for 164 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 67 | $5,914 | $76 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 50 | $5,430 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,693 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,477 | $105 |
| Simple destruction of growth of anus | 11 | $1,645 | $117 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 65 | 12 | 59 | 63 | 89 | 78 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 56 | – | 48 | 64 | 77 | 62 |
| Simple destruction of growth of anus | 19 | – | – | – | 12 | 14 |
| Extensive destruction of growth of anus | – | – | – | – | 22 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
164 Original Medicare patients in 2024. Average age 70 · Women 43% · Also on Medicaid 38% · Health risk score 1.77. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 65% · Chronic kidney disease 29% · Depression 29% · Diabetes 28% · Cancer 22% · Coronary heart disease 21% · Atrial fibrillation 15% · Heart failure 14% · COPD 14% · Stroke 9%.
The office billed $256,223, Medicare allowed $31,664 and paid $23,524; for 257 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 164 | 257 | 70 | 1.77 | $256,223 | $23,524 |
| 2023 | 220 | 351 | 69 | 2.09 | $382,126 | $35,984 |
| 2022 | 159 | 260 | 67 | 1.94 | $274,592 | $25,429 |
| 2021 | 163 | 297 | 68 | 2.09 | $247,210 | $29,552 |
| 2020 | 76 | 111 | 68 | 2.19 | $85,528 | $9,383 |
| 2019 | 178 | 339 | 63 | 2.12 | $265,037 | $31,294 |
| 2018 | 147 | 230 | 63 | 2.22 | $163,442 | $20,809 |
| 2017 | 189 | 336 | 62 | 2.13 | $248,496 | $29,520 |
| 2016 | 189 | 372 | 60 | 2.07 | $265,363 | $33,920 |
| 2015 | 129 | 196 | 58 | 2.06 | $127,667 | $42,764 |
| 2014 | 30 | 54 | 66 | 3.29 | $9,824 | $4,478 |
| 2013 | 27 | 67 | 64 | 2.98 | $11,266 | $5,289 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 65 | $6,650 | $86 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 69 | $6,443 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,971 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,911 | $156 |
| Extensive destruction of growth of anus | 19 | $3,205 | $146 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,925 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,713 | $71 |
| Simple destruction of growth of anus | 12 | $1,510 | $126 |
2022: 5 services
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 53 | $6,289 | $98 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 53 | $4,541 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,286 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,180 | $87 |
| Return visit (30+ min) | 16 | $1,764 | $68 |
2021: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,443 | $179 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 39 | $5,117 | $107 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 48 | $4,710 | $80 |
| Return visit (30+ min) | 16 | $3,245 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,678 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,798 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,455 | $121 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,587 | $93 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 12 | $1,048 | $87 |
| Long return visit (40+ min) | 13 | $809 | $45 |
2019: 8 services
| Long return visit (40+ min) | 29 | $6,342 | $89 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 49 | $5,354 | $96 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 53 | $4,960 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $4,103 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,721 | $181 |
| Simple destruction of growth of anus | 16 | $2,206 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,153 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,958 | $122 |
2018: 6 services
| Long return visit (40+ min) | 38 | $5,754 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,421 | $180 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 41 | $3,221 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,587 | $65 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 24 | $2,563 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,575 | $93 |
2017: 5 services
| Long return visit (40+ min) | 55 | $9,486 | $87 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 58 | $6,270 | $100 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 46 | $3,937 | $77 |
| Return visit (30+ min) | 28 | $2,497 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,680 | $65 |
2016: 7 services
| Long return visit (40+ min) | 45 | $11,339 | $94 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 47 | $4,292 | $86 |
| Biopsy of anus with magnification and chemical agent enhancement using an endoscope | 39 | $4,086 | $100 |
| Return visit (30+ min) | 40 | $3,979 | $62 |
| Simple destruction of growth of anus | 16 | $2,132 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,975 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,217 | $64 |
2015: 4 services
| Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) | 43 | $21,560 | $490 |
| Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | 34 | $10,243 | $263 |
| Long return visit (40+ min) | 30 | $4,187 | $95 |
| Return visit (30+ min) | 30 | $2,669 | $67 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $953 | $60 |
2013: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,732 | $58 |
Medicaid work
$40,517 in 2024
Medicaid paid $40,517 for 227 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DIAGNOSTIC ANOSCOPY | 119 | $22,231 |
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 63 | $15,300 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 32 | $2,670 |
| Diagnostic anoscopy with collection of specimen by brushing | 13 | $316 |
| 2024 | 227 | 4 | 19 | $40,517 |
| 2023 | 486 | 4 | 25 | $71,757 |
| 2022 | 188 | 6 | 21 | $18,726 |
| 2021 | 20 | 1 | 13 | $1,156 |
See the largest Medicaid services in earlier years
2023
| DIAGNOSTIC ANOSCOPY | 190 | $33,498 |
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 117 | $26,276 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 119 | $9,935 |
| Diagnostic anoscopy with collection of specimen by brushing | 60 | $2,048 |
2022
| DIAGNOSTIC ANOSCOPY | 46 | $6,565 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 61 | $4,366 |
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 13 | $4,273 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 25 | $2,253 |
| Diagnostic anoscopy with collection of specimen by brushing | 30 | $670 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $600 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $1,156 |
Drugs they prescribed that Part D paid
$387
Pharmacies billed $387 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 43% of their Part D prescriptions (13 of 30) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
29 generic and fewer than 11 brand-name prescriptions · $387 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 30 | 19 | 43% (13) | None | $387 |
| 2023 | 59 | 29 | None | 19% | $35,117 |
| 2022 | 630 | 43 | 5% (34) | None | $505,820 |
| 2021 | 793 | 36 | 4% (32) | None | $585,812 |
| 2020 | 644 | 35 | 3% (17) | None | $449,163 |
| 2019 | 1,829 | 62 | 3% (63) | None | $1,103,880 |
| 2018 | 1,954 | 87 | 4% (80) | None | $1,159,123 |
| 2017 | 3,223 | 128 | 7% (232) | None | $1,818,900 |
| 2016 | 3,296 | 126 | 7% (219) | None | $1,685,004 |
| 2015 | 616 | 67 | 7% (41) | 36% | $267,342 |
| 2014 | 190 | 14 | None | 47% | $90,444 |
| 2013 | 187 | 13 | None | None | $66,780 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 15 drugs
| Triumeq | 32 | $126,006 | $3,938 |
| Biktarvy | 27 | $122,203 | $4,526 |
| Odefsey | 12 | $41,878 | $3,490 |
| Pregabalin | 17 | $1,611 | $95 |
| Rosuvastatin | 27 | $608 | $23 |
| Hydrocodone-Acetaminophen | 15 | $491 | $33 |
| Tamsulosin | 20 | $365 | $18 |
| Atorvastatin | 41 | $230 | $6 |
| Alendronate | 18 | $214 | $12 |
| Acyclovir | 17 | $197 | $12 |
| Famotidine | 22 | $179 | $8 |
| Omeprazole | 11 | $179 | $16 |
| Losartan | 25 | $134 | $5 |
| Lisinopril | 22 | $84 | $4 |
| Metoprolol | 15 | $73 | $5 |
2021: 26 drugs
| Biktarvy | 36 | $131,953 | $3,665 |
| Triumeq | 35 | $118,090 | $3,374 |
| Symtuza | 13 | $56,299 | $4,331 |
| Prezcobix | 20 | $51,385 | $2,569 |
| Odefsey | 14 | $45,402 | $3,243 |
| Tivicay | 21 | $42,726 | $2,035 |
| Descovy | 12 | $37,561 | $3,130 |
| Pregabalin | 22 | $906 | $41 |
| Duloxetine | 12 | $872 | $73 |
| Lamivudine | 12 | $608 | $51 |
| Acyclovir | 16 | $592 | $37 |
| Albuterol Sulfate Hfa | 11 | $571 | $52 |
| Metoprolol | 24 | $492 | $21 |
| Tenofovir Disoproxil | 11 | $481 | $44 |
| Hydrocodone-Acetaminophen | 15 | $458 | $31 |
| Atorvastatin | 38 | $399 | $11 |
| Famotidine | 34 | $318 | $9 |
| Tamsulosin | 20 | $312 | $16 |
| Gabapentin | 20 | $257 | $13 |
| Omeprazole | 12 | $169 | $14 |
| Fluticasone Propionate | 20 | $163 | $8 |
| Amlodipine Besylate | 17 | $122 | $7 |
| Nevirapine | 11 | $112 | $10 |
| Losartan | 23 | $106 | $5 |
| Lisinopril | 18 | $89 | $5 |
| Clopidogrel | 11 | $53 | $5 |
2020: 19 drugs
| Triumeq | 31 | $94,995 | $3,064 |
| Biktarvy | 22 | $73,859 | $3,357 |
| Prezcobix | 19 | $39,830 | $2,096 |
| Tivicay | 18 | $35,833 | $1,991 |
| Edurant | 12 | $14,338 | $1,195 |
| Metformin Er Gastric | 11 | $12,863 | $1,169 |
| Rosuvastatin | 21 | $1,086 | $52 |
| Metoprolol | 29 | $450 | $16 |
| Acyclovir | 23 | $320 | $14 |
| Clindamycin | 11 | $253 | $23 |
| Gabapentin | 15 | $240 | $16 |
| Atorvastatin | 24 | $181 | $8 |
| Fluticasone Propionate | 15 | $156 | $10 |
| Trazodone | 18 | $149 | $8 |
| Amlodipine Besylate | 29 | $95 | $3 |
| Tamsulosin | 11 | $91 | $8 |
| Metformin Hcl Er | 13 | $73 | $6 |
| Famotidine | 12 | $67 | $6 |
| Alendronate | 17 | $51 | $3 |
2019: 58 drugs
| Triumeq | 65 | $187,180 | $2,880 |
| Tivicay | 91 | $164,080 | $1,803 |
| Biktarvy | 46 | $142,735 | $3,103 |
| Odefsey | 27 | $102,207 | $3,785 |
| Prezcobix | 51 | $102,176 | $2,003 |
| Descovy | 32 | $69,236 | $2,164 |
| Edurant | 50 | $56,923 | $1,138 |
| Isentress | 15 | $33,588 | $2,239 |
| Evotaz | 13 | $20,512 | $1,578 |
| Atazanavir Sulfate | 16 | $16,318 | $1,020 |
| Creon | 13 | $9,990 | $768 |
| Selzentry | 11 | $8,654 | $787 |
| Suboxone | 12 | $7,730 | $644 |
| Androderm | 12 | $7,684 | $640 |
| Testosterone | 15 | $6,361 | $424 |
| Janumet | 13 | $5,755 | $443 |
| Ritonavir | 13 | $3,241 | $249 |
| Flovent Hfa | 12 | $3,044 | $254 |
| Buprenorphine-Naloxone | 12 | $2,890 | $241 |
| Lamivudine | 24 | $2,523 | $105 |
| Duloxetine | 22 | $2,485 | $113 |
| Ventolin Hfa | 30 | $2,055 | $68 |
| Metoprolol | 74 | $2,042 | $28 |
| Tenofovir Disoproxil | 15 | $1,408 | $94 |
| Atorvastatin | 107 | $1,078 | $10 |
| Testosterone Cypionate | 21 | $731 | $35 |
| Acyclovir | 46 | $731 | $16 |
| Hydrocodone-Acetaminophen | 38 | $615 | $16 |
| Tamsulosin | 29 | $554 | $19 |
| Gabapentin | 32 | $549 | $17 |
| Trazodone | 43 | $483 | $11 |
| Fluticasone Propionate | 24 | $367 | $15 |
| Omeprazole | 32 | $361 | $11 |
| Benazepril | 28 | $337 | $12 |
| Methylphenidate | 11 | $301 | $27 |
| Clindamycin | 13 | $299 | $23 |
| Oxycodone | 16 | $288 | $18 |
| Amlodipine Besylate | 61 | $278 | $5 |
| Ketoconazole | 16 | $276 | $17 |
| Ibuprofen | 20 | $276 | $14 |
| Ranitidine | 28 | $272 | $10 |
| Alendronate | 35 | $179 | $5 |
| Amoxicillin | 13 | $176 | $14 |
| Famotidine | 20 | $172 | $9 |
| Pravastatin | 12 | $161 | $13 |
| Alfuzosin Hcl Er | 16 | $142 | $9 |
| Levothyroxine | 13 | $139 | $11 |
| Nevirapine | 13 | $133 | $10 |
| Selenium Sulfide | 11 | $132 | $12 |
| Temazepam | 11 | $119 | $11 |
| Glimepiride | 13 | $93 | $7 |
| Losartan | 15 | $92 | $6 |
| Lisinopril | 15 | $83 | $6 |
| Baclofen | 11 | $76 | $7 |
| Atenolol | 15 | $73 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $51 | $4 |
| Metformin Hcl Er | 16 | $45 | $3 |
| Hydrochlorothiazide | 11 | $24 | $2 |
2018: 60 drugs
| Triumeq | 79 | $227,976 | $2,886 |
| Tivicay | 98 | $169,468 | $1,729 |
| Genvoya | 43 | $124,626 | $2,898 |
| Descovy | 63 | $114,414 | $1,816 |
| Odefsey | 34 | $97,069 | $2,855 |
| Prezista | 52 | $81,552 | $1,568 |
| Prezcobix | 26 | $48,559 | $1,868 |
| Isentress | 17 | $31,932 | $1,878 |
| Evotaz | 16 | $26,062 | $1,629 |
| Edurant | 23 | $24,606 | $1,070 |
| Lyrica | 22 | $14,565 | $662 |
| Viread | 24 | $10,271 | $428 |
| Suboxone | 24 | $8,897 | $371 |
| Lamivudine | 34 | $7,912 | $233 |
| Androderm | 12 | $7,492 | $624 |
| Abacavir-Lamivudine | 12 | $7,255 | $605 |
| Norvir | 17 | $5,789 | $341 |
| Janumet | 12 | $4,925 | $410 |
| Testosterone | 16 | $4,816 | $301 |
| Ritonavir | 11 | $3,090 | $281 |
| Duloxetine | 19 | $2,591 | $136 |
| Metoprolol | 55 | $1,352 | $25 |
| Ventolin Hfa | 19 | $1,047 | $55 |
| Testosterone Cypionate | 27 | $1,016 | $38 |
| Atorvastatin | 92 | $949 | $10 |
| Tamsulosin | 43 | $931 | $22 |
| Gabapentin | 44 | $765 | $17 |
| Hydrocodone-Acetaminophen | 29 | $606 | $21 |
| Acyclovir | 50 | $600 | $12 |
| Fenofibrate | 11 | $569 | $52 |
| Rosuvastatin | 15 | $559 | $37 |
| Oxycodone | 18 | $474 | $26 |
| Valacyclovir | 15 | $443 | $30 |
| Omeprazole | 41 | $400 | $10 |
| Trazodone | 30 | $370 | $12 |
| Clindamycin | 14 | $330 | $24 |
| Amoxicillin-Clavulanate Potass | 13 | $253 | $19 |
| Benazepril | 26 | $235 | $9 |
| Sulfamethoxazole-Trimethoprim | 24 | $205 | $9 |
| Mupirocin | 13 | $204 | $16 |
| Mirtazapine | 22 | $199 | $9 |
| Ranitidine | 11 | $186 | $17 |
| Amoxicillin | 14 | $179 | $13 |
| Amlodipine Besylate | 52 | $155 | $3 |
| Ketoconazole | 11 | $143 | $13 |
| Methadone | 11 | $132 | $12 |
| Alendronate | 23 | $125 | $5 |
| Nevirapine | 12 | $122 | $10 |
| Ibuprofen | 13 | $118 | $9 |
| Baclofen | 11 | $117 | $11 |
| Citalopram Hbr | 20 | $111 | $6 |
| Naproxen | 13 | $93 | $7 |
| Glimepiride | 12 | $91 | $8 |
| Lisinopril | 24 | $88 | $4 |
| Metformin | 18 | $70 | $4 |
| Lorazepam | 11 | $67 | $6 |
| Valsartan | 11 | $66 | $6 |
| Terazosin | 13 | $60 | $5 |
| Losartan | 12 | $53 | $4 |
| Metformin Hcl Er | 15 | $47 | $3 |
2017: 81 drugs
| Triumeq | 133 | $348,763 | $2,622 |
| Tivicay | 156 | $246,267 | $1,579 |
| Descovy | 104 | $165,572 | $1,592 |
| Odefsey | 48 | $144,470 | $3,010 |
| Genvoya | 41 | $112,025 | $2,732 |
| Prezista | 71 | $103,427 | $1,457 |
| Prezcobix | 54 | $93,554 | $1,732 |
| Noxafil | 11 | $61,359 | $5,578 |
| Isentress | 37 | $60,094 | $1,624 |
| Truvada | 32 | $48,962 | $1,530 |
| Edurant | 48 | $46,543 | $970 |
| Reyataz | 27 | $43,492 | $1,611 |
| Evotaz | 26 | $41,989 | $1,615 |
| Androgel | 11 | $18,692 | $1,699 |
| Norvir | 53 | $16,927 | $319 |
| Lyrica | 28 | $15,607 | $557 |
| Lamivudine | 44 | $9,709 | $221 |
| Viread | 11 | $7,095 | $645 |
| Testosterone | 21 | $6,968 | $332 |
| Janumet | 19 | $6,946 | $366 |
| Metformin Hcl Er | 34 | $5,922 | $174 |
| Suboxone | 21 | $3,208 | $153 |
| Duloxetine | 20 | $2,627 | $131 |
| Metoprolol | 88 | $2,062 | $23 |
| Oxycodone-Acetaminophen | 44 | $2,061 | $47 |
| Rosuvastatin | 24 | $1,363 | $57 |
| Oxycodone | 33 | $1,286 | $39 |
| Bupropion Xl | 28 | $1,225 | $44 |
| Atorvastatin | 119 | $1,187 | $10 |
| Gabapentin | 56 | $1,087 | $19 |
| Tamsulosin | 56 | $1,027 | $18 |
| Omega-3 Acid Ethyl Esters | 12 | $1,004 | $84 |
| Hydrocodone-Acetaminophen | 55 | $939 | $17 |
| Testosterone Cypionate | 27 | $932 | $35 |
| Morphine Sulfate Er | 27 | $923 | $34 |
| Sulfamethoxazole-Trimethoprim | 49 | $868 | $18 |
| Valacyclovir | 19 | $829 | $44 |
| Diphenoxylate-Atropine | 12 | $747 | $62 |
| Morphine Sulfate | 13 | $721 | $55 |
| Acyclovir | 86 | $700 | $8 |
| Fenofibrate | 16 | $688 | $43 |
| Fluticasone Propionate | 42 | $626 | $15 |
| Amoxicillin | 25 | $570 | $23 |
| Clindamycin | 23 | $550 | $24 |
| Amitriptyline | 15 | $469 | $31 |
| Methadone | 24 | $448 | $19 |
| Ketoconazole | 11 | $414 | $38 |
| Trazodone | 65 | $360 | $6 |
| Methylphenidate | 11 | $313 | $28 |
| Digox | 13 | $311 | $24 |
| Omeprazole | 40 | $284 | $7 |
| Fluconazole | 13 | $270 | $21 |
| Ranitidine | 17 | $262 | $15 |
| Mirtazapine | 32 | $203 | $6 |
| Clopidogrel | 23 | $199 | $9 |
| Ibuprofen | 23 | $191 | $8 |
| Amlodipine Besylate | 64 | $191 | $3 |
| Mupirocin | 17 | $179 | $11 |
| Alendronate | 24 | $148 | $6 |
| Citalopram Hbr | 26 | $135 | $5 |
| Baclofen | 15 | $131 | $9 |
| Lorazepam | 22 | $116 | $5 |
| Benazepril | 24 | $108 | $4 |
| Venlafaxine Hcl Er | 17 | $105 | $6 |
| Temazepam | 12 | $94 | $8 |
| Lisinopril | 32 | $90 | $3 |
| Naproxen | 15 | $90 | $6 |
| Gemfibrozil | 13 | $88 | $7 |
| Acetaminophen-Codeine | 12 | $88 | $7 |
| Glimepiride | 11 | $84 | $8 |
| Finasteride | 11 | $84 | $8 |
| Tramadol | 13 | $77 | $6 |
| Metformin | 17 | $72 | $4 |
| Cyclobenzaprine | 12 | $57 | $5 |
| Terazosin | 12 | $54 | $4 |
| Diazepam | 15 | $51 | $3 |
| Losartan | 12 | $37 | $3 |
| Clonidine | 12 | $32 | $3 |
| Famotidine | 12 | $32 | $3 |
| Zolpidem | 13 | $31 | $2 |
| Levothyroxine | 11 | $18 | $2 |
2016: 92 drugs
| Triumeq | 106 | $255,959 | $2,415 |
| Tivicay | 145 | $226,270 | $1,560 |
| Truvada | 97 | $142,803 | $1,472 |
| Prezista | 84 | $114,673 | $1,365 |
| Complera | 35 | $84,815 | $2,423 |
| Prezcobix | 42 | $69,170 | $1,647 |
| Reyataz | 48 | $64,034 | $1,334 |
| Odefsey | 21 | $59,476 | $2,832 |
| Evotaz | 39 | $58,847 | $1,509 |
| Genvoya | 22 | $56,724 | $2,578 |
| Isentress | 37 | $52,933 | $1,431 |
| Edurant | 57 | $51,041 | $895 |
| Atripla | 20 | $47,871 | $2,394 |
| Epzicom | 21 | $32,563 | $1,551 |
| Descovy | 20 | $29,289 | $1,464 |
| Norvir | 81 | $26,990 | $333 |
| Viread | 14 | $15,814 | $1,130 |
| Androgel | 17 | $14,314 | $842 |
| Intelence | 13 | $14,126 | $1,087 |
| Lyrica | 26 | $13,964 | $537 |
| Lamivudine | 55 | $13,716 | $249 |
| Nexium | 20 | $7,653 | $383 |
| Crestor | 30 | $7,324 | $244 |
| Emtriva | 12 | $6,447 | $537 |
| Creon | 12 | $5,788 | $482 |
| Abacavir | 11 | $4,365 | $397 |
| Imiquimod | 15 | $3,722 | $248 |
| Asmanex | 13 | $3,715 | $286 |
| Tamsulosin | 76 | $3,012 | $40 |
| Duloxetine | 30 | $2,897 | $97 |
| Tramadol Hcl Er | 21 | $2,714 | $129 |
| Oxycodone-Acetaminophen | 48 | $2,662 | $55 |
| Metoprolol | 81 | $1,862 | $23 |
| Morphine Sulfate Er | 31 | $1,670 | $54 |
| Testosterone Cypionate | 24 | $1,370 | $57 |
| Oxycodone | 29 | $1,255 | $43 |
| Bupropion Xl | 45 | $1,210 | $27 |
| Valacyclovir | 35 | $1,186 | $34 |
| Omega-3 Acid Ethyl Esters | 13 | $1,186 | $91 |
| Diphenoxylate-Atropine | 17 | $1,013 | $60 |
| Atorvastatin | 117 | $1,000 | $9 |
| Hydrocodone-Acetaminophen | 45 | $940 | $21 |
| Gabapentin | 41 | $927 | $23 |
| Testosterone Enanthate | 11 | $869 | $79 |
| Doxycycline Hyclate | 11 | $842 | $77 |
| Clindamycin | 19 | $702 | $37 |
| Morphine Sulfate | 14 | $660 | $47 |
| Propranolol Hcl Er | 14 | $615 | $44 |
| Acyclovir | 65 | $602 | $9 |
| Mupirocin | 25 | $543 | $22 |
| Dutasteride | 14 | $537 | $38 |
| Methadone | 14 | $526 | $38 |
| Trazodone | 101 | $515 | $5 |
| Fluconazole | 17 | $511 | $30 |
| Nevirapine | 13 | $495 | $38 |
| Isoniazid | 13 | $451 | $35 |
| Fenofibrate | 12 | $445 | $37 |
| Methylphenidate | 11 | $372 | $34 |
| Fluticasone Propionate | 27 | $323 | $12 |
| Omeprazole | 43 | $310 | $7 |
| Digox | 12 | $299 | $25 |
| Ibuprofen | 36 | $245 | $7 |
| Amoxicillin | 13 | $241 | $19 |
| Amlodipine Besylate | 49 | $240 | $5 |
| Clopidogrel | 20 | $224 | $11 |
| Mirtazapine | 21 | $199 | $9 |
| Selenium Sulfide | 14 | $197 | $14 |
| Glipizide Er | 14 | $187 | $13 |
| Lisinopril | 32 | $183 | $6 |
| Lorazepam | 32 | $162 | $5 |
| Metformin | 37 | $155 | $4 |
| Baclofen | 15 | $141 | $9 |
| Citalopram Hbr | 34 | $129 | $4 |
| Finasteride | 16 | $125 | $8 |
| Sertraline | 18 | $124 | $7 |
| Benazepril | 27 | $110 | $4 |
| Montelukast | 11 | $95 | $9 |
| Ranitidine | 14 | $94 | $7 |
| Glipizide | 13 | $93 | $7 |
| Alendronate | 11 | $93 | $8 |
| Metformin Hcl Er | 24 | $83 | $3 |
| Sulfamethoxazole-Trimethoprim | 27 | $83 | $3 |
| Olanzapine | 12 | $67 | $6 |
| Clonazepam | 13 | $64 | $5 |
| Famotidine | 18 | $64 | $4 |
| Levothyroxine | 12 | $57 | $5 |
| Paroxetine | 12 | $54 | $4 |
| Carvedilol | 11 | $52 | $5 |
| Furosemide | 24 | $51 | $2 |
| Cyclobenzaprine | 15 | $49 | $3 |
| Diazepam | 15 | $47 | $3 |
| Lansoprazole | 12 | $39 | $3 |
2015: 16 drugs
| Complera | 18 | $39,800 | $2,211 |
| Tivicay | 27 | $35,543 | $1,316 |
| Triumeq | 13 | $28,780 | $2,214 |
| Truvada | 20 | $27,210 | $1,361 |
| Prezista | 19 | $20,351 | $1,071 |
| Isentress | 18 | $18,159 | $1,009 |
| Norvir | 21 | $7,676 | $366 |
| Doxycycline Hyclate | 11 | $1,073 | $98 |
| Oxycodone-Acetaminophen | 11 | $320 | $29 |
| Tamsulosin | 14 | $273 | $19 |
| Hydrocodone-Acetaminophen | 11 | $230 | $21 |
| Acyclovir | 14 | $168 | $12 |
| Atorvastatin | 15 | $162 | $11 |
| Trazodone | 15 | $120 | $8 |
| Naproxen | 11 | $71 | $6 |
| Benazepril | 13 | $54 | $4 |
2014: 7 drugs
| Truvada | 20 | $26,030 | $1,301 |
| Reyataz | 16 | $19,001 | $1,188 |
| Norvir | 16 | $4,176 | $261 |
| Atorvastatin | 17 | $163 | $10 |
| Paroxetine | 11 | $103 | $9 |
| Loperamide | 17 | $82 | $5 |
| Metformin | 15 | $52 | $3 |
2013: 8 drugs
| Truvada | 15 | $18,936 | $1,262 |
| Reyataz | 12 | $13,418 | $1,118 |
| Norvir | 11 | $2,803 | $255 |
| Atorvastatin | 13 | $334 | $26 |
| Fenofibrate | 11 | $241 | $22 |
| Paroxetine | 11 | $91 | $8 |
| Lisinopril | 12 | $84 | $7 |
| Loperamide | 12 | $74 | $6 |
Money from drug and device companies
$72 in 2019
A payment is not proof that care is biased.
| Janssen Biotech | Symtuza | $72 | 5 payments
|
See all 5 published payments
| Janssen Biotech | Meals · 2019-06-28 | Symtuza | $14 |
| Janssen Biotech | Meals · 2019-05-24 | Symtuza | $15 |
| Janssen Biotech | Meals · 2019-03-29 | Symtuza | $14 |
| Janssen Biotech | Meals · 2019-03-01 | Symtuza | $15 |
| Janssen Biotech | Meals · 2019-01-25 | Symtuza | $15 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1588823538
- Licence
- PA MD448582
- Trained
- Columbia University College of Physicians and Surgeons, 2007 · 19 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 51 N 39th St, 3910 Building, 2nd Floor, Philadelphia, PA, 19104
- NPI first listed
- 2008-06-05
- NPI last updated
- 2013-06-28
This is when the NPI record was last certified, not a medical board exam.